Good morning to you all. Please find enclosed a summary of the breaking small-cap and micro-cap financial news we highlighted on AGORACOM Small Cap TV this morning. It’s Aug 11th, 2011, and we’ve found 8 great press releases to report on at the open. Another great day for small-cap and micro-cap financial news. To watch the show live every morning at 9:30 AM, visit our front page.

Minera Andes Inc. (the "Company" or "Minera Andes") (TSX:MAI)(OTCBB:MNEAF)

Minera Andes Announces Second Quarter 2011 Financial Results

Minera Andes Inc. (the "Company" or "Minera Andes") (TSX:MAI)(OTCBB:MNEAF) is pleased to announce net income of $10.7 million ($0.04 per share basic and diluted) for the quarter ended June 30, 2011, an increase of $6.4 million compared to net income of $4.3 million ($0.02 per share basic and diluted), for the same period in 2010.

The increase is primarily attributable to the strong performance of the San Jose Mine where our 49% ownership interest is reflected in our income from investment in Minera Santa Cruz S.A. ("MSC") which increased from $4.1 million in Q2 2010 to $13.5 million in Q2 2011. Comparing Q2 2010 to Q2 2011, silver ounces sold at MSC increased from 1,295,000 ounces ("oz") to 1,584,000 oz reflecting an increase of 22% and gold oz sold remained at 22,000 oz. MSC also benefitted from higher silver and gold prices: the average weighted gross sale price for silver was $36.18 per oz in Q2 2011 compared to $18.21 per oz in Q2 2010, a 99% increase; the average weighted gross sale price for gold was $1,496 per oz for gold compared to $1,233 per oz, a 21% increase.

About Minera Andes

Minera Andes is an exploration company exploring for gold, silver and copper in Argentina with three significant assets: A 49% interest in Minera Santa Cruz SA, owner of the San Jose Mine in close proximity to Goldcorp's Cerro Negro project; 100% ownership of the Los Azules copper deposit with an inferred mineral resource of 10.3 billion pounds of 0.73% Cu copper and an indicated resource of 2.2 billion pounds of 0.52% Cu copper; and, 100% ownership of a large portfolio of exploration properties in Santa Cruz province, Argentina, including properties bordering the Cerro Negro project in Santa Cruz Province.

Last Trade: 2.2952 Week: 3.58 – 0.7682Market Cap: 647.38 Million

Link to HUB

China Pharma Holdings, Inc. (NYSE AMEX: CPHI)

China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results

China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a specialty pharmaceuticals company in China, today announced financial results for the quarter ended June 30, 2011.

Second Quarter 2011 Highlights

Revenue increased 18% to $19.6 million from $16.6 million in the Second quarter of 2010.

Cashflow from operations rose 10% to $3.6 million from $3.3 million in first six months of 2010.

Gross profit for the three months ended June 30, 2011 was $7.28 million, which was approximately 3% higher compared to $7.04 million in the second quarter of 2010. Our gross margin for the second quarter of 2011 was 37.2%, compared to 42.4% in the corresponding quarter of 2010.

Operating income was $5.8 million in the second quarter of 2011, down 3% from $6.0 million in the second quarter of 2010.

Net income for the second quarter of 2011 was $5.1 million, or $0.12 per basic and diluted share, compared to $6.1 million, or $0.14 per basic and diluted share, in the second quarter of 2010.

Six Months Results

Revenues for the six months ended June 30, 2011 were $37.7 million, up 19% from revenues of $31.7 million for the six months ended June 30, 2010. Gross profit for the six months ended June 30, 2011 was $14.2 million, up 7% from gross profit of $13.2 million for the corresponding period of 2010. Gross margin was 37.5%, compared to 41.5% for the first six months of 2010. Operating income was $11.1 million, up 2.9% from $10.8 million for the first six months of 2010. Net income was $10.2 million, or $0.23 per basic and diluted share, compared to $11.4 million, or $0.26 per basic and diluted share, for the same period a year ago.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a rapidly growing specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases.

Last Trade: 2.2552 Week: 3.27 – 1.59Market Cap: 97.66 Million

Link to HUB

Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI)

Cord Blood America Six Month Revenues Up 61 Percent; Gross Profit Up 100 Percent

Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced revenues of $2.89 million for the first six months of 2011, up 61 percent compared to revenues of $1.79 million in the same period in 2010. Revenues for the second quarter ended June 30, 2011 totaled $1.43 million, up 50 percent compared to revenues of $951,561 in the second quarter of 2010.

Gross profit totaled $1.96 million for the first half of 2011, up 100 percent compared to 2010, and $970,603 in the second quarter of 2011, up 76 percent from the comparable period in 2010. "We anticipate that, by growing and expanding our business, and processing and storing cord blood in our own facilities, our direct costs will continue to decrease and our gross profits will continue to improve," said Matthew Schissler, co-founder and CEO.

Biocordcell Argentina S.A., Buenos Aires, contributed $890,000 to the six month revenue totals and Stellacure, GmbH, Hamburg Germany, which serves families in Germany, Spain and Italy, contributed $288,000 to revenues through June 30, 2011. The balance, $1.7 million, is from storing umbilical cord blood stem cells at birth for families in the U.S. and the collection of placentas for major tissue banks.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders.

Last Trade: 0.10452 Week: 0.30 – 0.06Market Cap: 7.09 Million